BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

872 related articles for article (PubMed ID: 24768914)

  • 1. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway.
    Xiong D; Liou Y; Shu J; Li D; Zhang L; Chen J
    Exp Mol Pathol; 2014 Jun; 96(3):411-21. PubMed ID: 24768914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel role of ribonuclease inhibitor in regulation of epithelial-to-mesenchymal transition and ILK signaling pathway in bladder cancer cells.
    Yao X; Li D; Xiong DM; Li L; Jiang R; Chen JX
    Cell Tissue Res; 2013 Sep; 353(3):409-23. PubMed ID: 23703635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay between intergrin-linked kinase and ribonuclease inhibitor affects growth and metastasis of bladder cancer through signaling ILK pathways.
    Zhuang X; Lv M; Zhong Z; Zhang L; Jiang R; Chen J
    J Exp Clin Cancer Res; 2016 Aug; 35(1):130. PubMed ID: 27576342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of integrin-linked kinase inhibits epithelial-to-mesenchymal transition and metastasis in bladder cancer cells.
    Zhu J; Pan X; Zhang Z; Gao J; Zhang L; Chen J
    Cell Signal; 2012 Jun; 24(6):1323-32. PubMed ID: 22570869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
    Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of integrin-linked kinase correlates with malignant phenotype in non-small cell lung cancer and promotes lung cancer cell invasion and migration via regulating epithelial-mesenchymal transition (EMT)-related genes.
    Chen D; Zhang Y; Zhang X; Li J; Han B; Liu S; Wang L; Ling Y; Mao S; Wang X
    Acta Histochem; 2013 Mar; 115(2):128-36. PubMed ID: 22683084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small interfering RNA targeting integrin-linked kinase inhibited the growth and induced apoptosis in human bladder cancer cells.
    Gao J; Zhu J; Li HY; Pan XY; Jiang R; Chen JX
    Int J Biochem Cell Biol; 2011 Sep; 43(9):1294-304. PubMed ID: 21601006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small interfering RNA targeting ILK inhibits metastasis in human tongue cancer cells through repression of epithelial-to-mesenchymal transition.
    Xing Y; Qi J; Deng S; Wang C; Zhang L; Chen J
    Exp Cell Res; 2013 Aug; 319(13):2058-2072. PubMed ID: 23707970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of integrin-linked kinase (ILK) promotes migration and invasion of colorectal cancer cells by inducing epithelial-mesenchymal transition via NF-κB signaling.
    Yan Z; Yin H; Wang R; Wu D; Sun W; Liu B; Su Q
    Acta Histochem; 2014 Apr; 116(3):527-33. PubMed ID: 24360977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of homeodomain-interacting protein kinase-2 contributes to bladder cancer metastasis by regulating Wnt signaling.
    Tan M; Gong H; Zeng Y; Tao L; Wang J; Jiang J; Xu D; Bao E; Qiu J; Liu Z
    J Cell Biochem; 2014 Oct; 115(10):1762-7. PubMed ID: 24824041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulator of cullins-1 expression knockdown suppresses the malignant progression of muscle-invasive transitional cell carcinoma by regulating mTOR/DEPTOR pathway.
    Wang W; Chen H; Liu Z; Qu P; Lan J; Chen H; Zou L; Qiu J
    Br J Cancer; 2016 Feb; 114(3):305-13. PubMed ID: 26742010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
    Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J
    Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer.
    Hu H; Wang YL; Wang GW; Wong YC; Wang XF; Wang Y; Xu KX
    Urol Oncol; 2013 Oct; 31(7):1242-53. PubMed ID: 22226665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen receptor inducing bladder cancer progression by promoting an epithelial-mesenchymal transition.
    Jitao W; Jinchen H; Qingzuo L; Li C; Lei S; Jianming W; Zhenli G
    Andrologia; 2014 Dec; 46(10):1128-33. PubMed ID: 24329492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
    Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
    Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of integrin-linked kinase in the regulation of bladder cancer invasion.
    Matsui Y; Assi K; Ogawa O; Raven PA; Dedhar S; Gleave ME; Salh B; So AI
    Int J Cancer; 2012 Feb; 130(3):521-31. PubMed ID: 21351095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribonuclease inhibitor up-regulation inhibits the growth and induces apoptosis in murine melanoma cells through repression of angiogenin and ILK/PI3K/AKT signaling pathway.
    Li L; Pan XY; Shu J; Jiang R; Zhou YJ; Chen JX
    Biochimie; 2014 Aug; 103():89-100. PubMed ID: 24769129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-451 inhibits invasion and proliferation of bladder cancer by regulating EMT.
    Zeng T; Peng L; Chao C; Fu B; Wang G; Wang Y; Zhu X
    Int J Clin Exp Pathol; 2014; 7(11):7653-62. PubMed ID: 25550801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of ribonuclease inhibitor expression with siRNA in non-invasive bladder cancer cell line BIU-87 promotes growth and metastasis potentials.
    Chen J; Ou-Yang X; Gao J; Zhu J; He X; Rong J
    Mol Cell Biochem; 2011 Mar; 349(1-2):83-95. PubMed ID: 21125316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
    Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.